Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 25, 2024 17:46 ET | Source: Appili Therapeutics Inc.

Appili Therapeutics Reports Fiscal Year 2024 Financial and Operational Results

Appili Therapeutics Reports Fiscal Year 2024 Financial and Operational Results
April 26, 2024 19:03 ET | Source: Appili Therapeutics Inc.

Appili Therapeutics Announces Additional Bridge Loan from Bloom Burton & Co.

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES HALIFAX, Nova Scotia, April 26, 2024 (GLOBE NEWSWIRE) -- Appili Therapeutics Inc. (TSX: APLI;...
April 02, 2024 07:30 ET | Source: Appili Therapeutics Inc.

Appili Therapeutics Signs Definitive Agreement to be Acquired by Aditxt, Inc.

Transaction consideration provides a significant premium to the Appili shareholders Combined enterprise expected to provide enhanced synergies and resources to advance key programs NOT FOR...
March 12, 2024 07:12 ET | Source: Appili Therapeutics Inc.

Researchers Publish Manuscript on the Prevention and Emergency Response to Tularemia Outbreaks

HALIFAX, Nova Scotia, March 12, 2024 (GLOBE NEWSWIRE) -- Appili Therapeutics Inc. (TSX:APLI; OTCPink: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for...
February 13, 2024 17:49 ET | Source: Appili Therapeutics Inc.

Appili Therapeutics Reports Financial and Operational Results for Third Quarter of Fiscal Year 2024

FDA approved LIKMEZ™ (ATI-1501) for Metronidazole Oral Suspension 500mg/5mL Additional USAFA funding commitment from the U.S. Air Force Academy, intended to advance the ATI-1701 program toward an IND...

keyboard_arrow_left Previous Page